PLK1 and cancer: Importantly, several studies have shown that inhibiting PLK1 expression or function by antibodies, RNAi, or small molecule inhibitors leads to mitotic arrest and apoptotic cell death in a wide range of human cancer cells, and is sufficient to prompt tumor regression in mouse xenograft models [105].